HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshiki Takemoto Selected Research

sotorasib

1/2021KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshiki Takemoto Research Topics

Disease

17Lung Neoplasms (Lung Cancer)
09/2023 - 08/2014
9Neoplasms (Cancer)
09/2023 - 01/2016
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 01/2016
3Adenocarcinoma of Lung
01/2019 - 08/2014
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021
1Chronic Obstructive Pulmonary Disease (COPD)
09/2021
1Disease Progression
10/2020
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
06/2019
1Amyloidosis
06/2019
1Lymphoma (Lymphomas)
06/2019
1Interstitial Lung Diseases (Interstitial Lung Disease)
10/2017
1Adenocarcinoma
10/2017
1Melanoma (Melanoma, Malignant)
01/2016
1Esophageal Fistula
01/2013
1Esophageal Perforation
01/2013
1Fistula
01/2013

Drug/Important Bio-Agent (IBA)

10Tyrosine Kinase InhibitorsIBA
09/2023 - 08/2014
5ErbB Receptors (EGF Receptor)IBA
12/2018 - 08/2014
3AfatinibIBA
12/2021 - 12/2015
2Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2021 - 08/2014
2osimertinibIBA
01/2021 - 04/2016
1mobocertinibIBA
09/2023
1Biomarkers (Surrogate Marker)IBA
09/2023
1capmatinibIBA
11/2022
1tepotinibIBA
11/2022
1Hemoglobins (Hemoglobin)IBA
09/2021
1adagrasibIBA
01/2021
1sotorasibIBA
01/2021
1Fibrinogen (Factor I)FDA Link
11/2020
1fibrin fragment D (D-dimer)IBA
11/2020
1Circulating Tumor DNAIBA
10/2020
1Methylnitronitrosoguanidine (MNNG)IBA
10/2019
1Amyloid (Amyloid Fibrils)IBA
06/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1HM781-36BIBA
12/2018
1Gefitinib (Iressa)FDA Link
01/2018
1dacomitinibIBA
01/2018
1Therapeutic UsesIBA
01/2018
1Carcinoembryonic AntigenIBA
10/2017
1src-Family KinasesIBA
01/2017
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2017
1Transforming Growth Factor beta (TGF-beta)IBA
01/2017
1Dasatinib (BMS 354825)FDA Link
01/2017
1rociletinibIBA
04/2016
1AntibodiesIBA
01/2016
1VimentinIBA
01/2016
1LigandsIBA
01/2016
1neratinibIBA
12/2015
1Insulin-Like PeptidesIBA
08/2014
1Phosphotransferases (Kinase)IBA
08/2014
1Fibrin Tissue Adhesive (Fibrin Sealant)IBA
01/2013

Therapy/Procedure

3Therapeutics
01/2021 - 08/2014
1Aftercare (After-Treatment)
12/2021
1Renal Dialysis (Hemodialysis)
06/2019
1Lymph Node Excision (Lymph Node Dissection)
11/2015
1Segmental Mastectomy (Lumpectomy)
11/2014